Lefamulin Evaluation Against Pneumonia 2 (LEAP 2) Study Results Published in the Journal of the American Medical Association

NEXT STORY
Kezar Life Sciences to Present at the 2019 Cantor Global Healthcare Conference
PREV STORY
Aravive Presents Positive Data from Initial 12 Patients in Phase 1b Portion of its Phase 1b/2 Ovarian Cancer Study of AVB-500 in Late Breaking Oral Presentation at European Society for Medical Oncology Congress in Barcelona
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases

author_avatar
NASDAQ Market News

Achroma Corp. Announces Global Survey Results of 226 People with Achromatopsia

More than One-Third of People with Achromatopsia Were Misdiagnosed with Retinal or Cone Dystrophy ...

author_avatar
NASDAQ Market News

Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia

author_avatar
NASDAQ Market News